Insider · CIK 0001324466

Mento Steven J

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001324466

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	DRMADermata Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2025-01-13	DRMADermata Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-01-04	DRMADermata Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-03-10	Histogen Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−18.9K sh	—	—	0
2023-03-10	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+158K sh	—	—	158,055
2023-03-10	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+55.5K sh	—	—	55,532
2023-03-10	Histogen Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−7,582 sh	—	—	0
2022-11-07	Histogen Inc.Restricted Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−11.4K sh	$250.00	−$2.85M	0
2022-02-24	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+152K sh	—	—	151,642
2022-01-03	DRMADermata Therapeutics, Inc. · Stock Option (right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-11-08	Histogen Inc.Restricted Stock UnitA Award	Director, President and CEO	AAward	+228K sh	—	—	228,395
2021-11-08	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+378K sh	—	—	377,830
2021-09-02	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+20K sh	—	—	20,000
2021-08-17	DRMADermata Therapeutics, Inc. · Stock Option (right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-10-07	Histogen Inc.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+20K sh	—	—	20,000
2020-05-22	Histogen Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+65K sh	—	—	71,000
2020-05-22	Histogen Inc.F Tax Payment	Director, President and CEO	FTax Payment	−31.4K sh	$0.56	−$17.6K	39,572
2020-05-22	Histogen Inc.Restricted Stock UnitsM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−65K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−400K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−150K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−50K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−20K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−37.5K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−173K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−120K sh	—	—	0
2019-08-01	Histogen Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−350K sh	—	—	0
2019-08-01	Histogen Inc.Restricted Stock UnitsA Award	Director, President and CEO	AAward	+650K sh	—	—	650,000
2019-02-07	Histogen Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+350K sh	—	—	350,000
2018-06-11	SGMOQSANGAMO THERAPEUTICS, INCA Award	Director	AAward	+2,500 sh	—	—	14,332
2018-06-11	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-05-04	Histogen Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+60K sh	$0.99	+$59.4K	60,000
2018-05-04	Histogen Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−60K sh	—	—	147,070
2018-04-02	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−7,115 sh	$18.39	−$131K	11,932
2018-04-02	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$7.77	+$77.7K	19,047
2018-04-02	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−100 sh	$18.90	−$1,890	11,832
2018-04-02	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2018-03-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2018-03-01	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.41	+$32.1K	8,480
2018-03-01	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$5.03	+$50.3K	18,480
2018-03-01	SGMOQSANGAMO THERAPEUTICS, INC · StockOption (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2018-03-01	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−9,433 sh	$23.27	−$220K	9,047
2018-02-04	Histogen Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+120K sh	—	—	120,000
2018-02-01	SGMOQSANGAMO THERAPEUTICS, INC · StockOption (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2018-02-01	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$6.41	+$32.1K	5,000
2018-02-01	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$10.17	+$102K	15,000
2018-02-01	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−11.5K sh	$20.59	−$237K	3,480
2018-02-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2017-06-05	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	−10K sh	—	—	10,000
2017-01-26	Histogen Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+173K sh	—	—	172,500
2016-12-20	Histogen Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,051 sh	—	—	207,070

Recent filings

Accepted (ET)
Jan 64
Mento Steven J0001493152-26-000695
SEC(opens sec.gov)
Jan 144
Mento Steven J0001654954-25-000397
SEC(opens sec.gov)
Jan 54
Mento Steven J0001654954-24-000300
SEC(opens sec.gov)
Mar 144
Mento Steven J0001209191-23-018474
SEC(opens sec.gov)
Nov 94
Mento Steven J0001209191-22-056212
SEC(opens sec.gov)
Feb 254
Mento Steven J0001209191-22-013211
SEC(opens sec.gov)
Jan 54
Mento Steven J0000905718-22-000042
SEC(opens sec.gov)
Nov 104
Mento Steven J0001209191-21-063872
SEC(opens sec.gov)
Sep 34
Mento Steven J0001209191-21-054741
SEC(opens sec.gov)
Aug 174
Mento Steven J0000905718-21-001114
SEC(opens sec.gov)
Oct 94
Mento Steven J0001209191-20-054437
SEC(opens sec.gov)
May 274
Mento Steven J0000899243-20-014288
SEC(opens sec.gov)
Aug 14
Mento Steven J0001209191-19-044008
SEC(opens sec.gov)

Companies

Address

3525 DEL MAR HEIGHTS RD., #322

SAN DIEGO, CA, 92130